NQO1 C609T polymorphism and colorectal cancer susceptibility: A meta-analysis

Archives of Medical Science

Volumn 10, Issue 4, 2014, Pages 651-660

  Zheng, Bo'An ^a   Wang, Zishu ^b   Chai, Rui ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

Colorectal cancer; Meta analysis; NQO1; Polymorphism

Indexed keywords

NADPH QUININE OXIDOREDUCTASE 1; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ALLELE; ASIAN; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; META ANALYSIS (TOPIC); REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84907465368     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.44856     Document Type: Review

References (45)

1. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 1672-94.
2. Klimczak A, Kempinska-Miroslawska B, Mik M, Dziki L, Dziki A. Incidence of colorectal cancer in Poland in 1999-2008. Arch Med Sci 2011; 7: 673-8.
3. Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 2010; 92: 471-90.
4. Smolinska K, Paluszkiewicz P. Risk of colorectal cancer in relation to frequency and total amount of red meat consumption. Systematic review and meta-analysis. Arch Med Sci 2010; 6: 605-10.
5. Liu X, Shan Y, Xue B. Int7G24A polymorphism (rs334354) and cancer risk. Arch Med Sci 2013; 9: 3-7.
6. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 2000; 129: 77-97. (Pubitemid 32061055)
7. Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004; 65: 1238-47. (Pubitemid 38543494)
8. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 2002; 4: 62-70. (Pubitemid 44698580)
9. Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2422-6. (Pubitemid 46048299)
10. Hlavata I, Vrana D, Smerhovsky Z, et al. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol Rep 2010; 24: 1347-53.
11. Nisa H, Kono S, Yin G, et al. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. BMC Cancer 2010; 10: 274.
12. Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev 2010; 11: 209-13.
13. van der Logt EM, Bergevoet SM, Roelofs HM, et al. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat Res 2006; 593: 39-49. (Pubitemid 43113361)
14. Sachse C, Smith G, Wilkie MJ, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002; 23: 1839-49. (Pubitemid 35363272)
15. Peng XE, Jiang YY, Shi XS, Hu ZJ. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population. Gene 2013; 521: 105-10.
16. Ding R, Lin S, Chen D. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 2012; 27: 885-92.
17. Chen J, Lin Y, Zhang R, Huang ZJ, Pan XG. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis. Arch Med Res 2012; 43: 58-66.
18. Wang Y, Zhang G, Luo Y. Association between NQO1 C609T polymorphism and colorectal cancer risk. Tumor Biol 2013; 34: 4027-32.
19. Zhu CL, Huang Q, Liu CH, Lin XS, Xie F, Shao F. NAD(P) H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis. Asian Pac J Cancer Prev 2013; 14: 2349-54.
20. Thakkinstian A, McKay GJ, McEvoy M, et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 2011; 173: 1365-79.
21. Yu H, Liu H, Wang LE, Wei Q. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One 2012; 7: e30566.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
24. Lafuente MJ, Casterad X, Trias M, et al. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 2000; 21: 1813-9.
25. Su XL, Yan MR, Yang L. NQO1 C609T polymorphism correlated to colon cancer risk in farmers from western region of Inner Mongolia. Chin J Cancer Res 2012; 24: 317-22.
26. Zhang Y, Wang ZT, Zhong J. Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in Asians. Genet Mol Res 2012; 11: 2328-37.
27. Yuan W, Xu L, Chen W, et al. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 2011; 125: 467-72.
28. Wang Z, Hu J, Zhong J. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk. DNA Cell Biol 2012; 31: 560-7.
29. Guo S, Gao M, Li X, et al. Lack of Association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One 2012; 7: e47939.
30. Begleiterabc A, Leith MK, Doherty GP, Digbya TJ, Pan S. Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines. Biochem Pharmacol 2001; 61: 955-64. (Pubitemid 32247384)
31. Siemankowski LM, Morreale J, Butts BD, Briehl MM. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase. Cancer Res 2000; 60: 3638-44. (Pubitemid 30482187)
32. Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A 2002; 99: 3099-104. (Pubitemid 34240592)
33. Begleiter A, Sivananthan K, Lefas GM, Maksymiuk AW, Bird RP. Inhibition of colon carcinogenesis by post-initiation induction of NQO1 in Sprague-Dawley rats. Oncol Rep 2009; 21: 1559-65.
34. Long DJ 2nd, Waikel RL, Wang XJ, Roop DR, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a] -anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 2001; 93: 1166-70. (Pubitemid 32780969)
35. Nioi P, Hayes JD. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 2004; 555: 149-71. (Pubitemid 39359178)
36. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 2765-78.
37. Hou L, Chatterjee N, Huang WY, et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005; 26: 1122-8. (Pubitemid 41214306)
38. Mitrou PN, Watson MA, Loktionov AS, et al. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis 2007; 28: 875-82. (Pubitemid 46523343)
39. Hakura A, Seki Y, Sonoda J, et al. Rapid induction of colonic adenocarcinoma in mice exposed to benzo[a] pyrene and dextran sulfate sodium. Food Chem Toxicol 2011; 49: 2997-3001.
40. Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N. Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005; 14: 2030-4. (Pubitemid 41161219)
41. Harth V, Donat S, Ko Y, Abel J, Vetter H, Bruning T. NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer. Arch Toxicol 2000; 73: 528-31. (Pubitemid 30062483)
42. Mitrou P, Watson M, Bingham S, Stebbings WS, Speakman CT, Loktionov A. NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk. IARC Sci Publ 2002; 156: 495-7.
43. Hamajima N, Matsuo K, Iwata H, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol 2002; 7: 103-8. (Pubitemid 34538454)
44. .Enyong D, Zhenxia L, Jieping S, Yaqin Y, Jing Z. NAD(P)H: quinone oxidoreductase gene polymorphism and its association with colorectal cancer. Chinese J Clin Oncol 2004; 31: 89-91.
45. Peng X, Jiang Y, Shi X, et al. Relationship between NQO1 C609T gene polymorphism and risk of colorectal cancer. Chin J Public Health 2010; 26: 415-6.